Follow
Daria Savenkova
Title
Cited by
Cited by
Year
Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer
AK Nurgalieva, VE Popov, VS Skripova, LF Bulatova, DV Savenkova, ...
Biochemistry and Biophysics Reports 28, 101104, 2021
82021
Physcion enhances sensitivity of pancreatic adenocarcinoma and lung carcinoma cell lines to cisplatin
DV Savenkova, КV Havrysh, VS Skripova, NE Ionova, AK Nurgalieva, ...
BioNanoScience 10, 549-553, 2020
42020
53P Expression of sodium-dependent phosphate transporter NaPi2b is downregulated in malignant ovarian tumors after neoadjuvant chemotherapy
AK Nurgalieva, S Safina, E Shakirova, V Filonenko, V Skripova, ...
Annals of Oncology 32, S1361-S1362, 2021
22021
Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells
L Bulatova, D Savenkova, A Nurgalieva, D Reshetnikova, A Timonina, ...
Frontiers in Molecular Biosciences 9, 895911, 2022
12022
26P Structurally constrained tumor-specific epitope within the largest extracellular domain of sodium-dependent phosphate transporter NaPi2b
LF Bulatova, V Skripova, A Nurgalieva, D Reshetnikova, DV Savenkova, ...
Annals of Oncology 32, S368-S369, 2021
12021
65P Transmembrane distribution of phosphatidylethanolamine in plasma membrane of ovarian cancer cells under conditions mimicking tumor microenvironment
D Savenkova, LF Bulatova, I Makarenko, D Nedorezova, I Levashov, ...
ESMO Open 8 (1), 2023
2023
Recognition of cysteine mutant forms of the sodiumdependent phosphate transporter NaPi2b by monoclonal antibodies in ovarian cancer cells OVCAR-8
L Bulatova, D Savenkova, D Reshetnikova, A Timonina, A Nurgalieva, ...
CELL DEATH DISCOVERY 8, 5-6, 2022
2022
81P Effect of disulfide bonds and N-glycosylation on the recognition of the NaPi2b transporter by monoclonal antibodies
D Reshetnikova, LF Bulatova, V Skripova, D Savenkova, AK Nurgalieva, ...
Annals of Oncology 33, S1408, 2022
2022
Topology of sodium-dependent phosphate transporter NaPi2b in live ovarian cancer cells
LB Minigulova, D Savenkova, V Skripova, A Nurgalieva, D Reshetnikova, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022
2022
Lipid-assisted folding defines recognition of conformationally exposed cancer specific napi2b epitope by monoclonal antibodies in ovarian cancer cells
D Savenkova, LB Minigulova, A Kozlova, R Vlasenkova, N Akberova, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022
2022
Interplay of Lipid-Assisted and Oxidative Folding of Largest Extracellular Domain Defines Transport Function of Secondary Transporter NaPi2b in Cancer Cells
DV Savenkova, DD Reshetnikova, LF Bulatova, AS Kozlova, NI Akberova, ...
Липиды 2021, 169-171, 2021
2021
The combined action of cisplatin and Physcion increases the ROS level in the lung and pancreas cancer cells
DV Savenkova, K Havrysh, VS Skripova, AK Nurgalieva, LF Minigulova, ...
HUMAN GENE THERAPY 30 (11), A62-A62, 2019
2019
Investigation of the combined action of cisplatin and 6-phosphogluconate dehydrogenase inhibitor on pancreatic and lung cancer cell lines
DV Savenkova, LF Minigulova, KV Havrysh, VS Skripova, RG Kiyamova
Annals of Oncology 29, vi5, 2018
2018
The effect of small molecule compounds Physcion and PFI-3 on the sensitivity of the tumor cell lines SCC61 and AcPC-1 to cisplatin
D Savenkova, L Minigulova, K Havrysh, V Skripova, I Serebriiskii, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 48, 220-221, 2018
2018
Physcion Enhances Sensitivity of Pancreatic Adenocarcinoma and Lung Carcinoma Cell Lines to Cisplatin
LF Minigulova, MV Bogdanov, NE Ionova, VS Skripova, DV Savenkova, ...
Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer
SZ Safina, RA Vlasenkova, EZ Shakirova, MV Bogdanov, VS Skripova, ...
The system can't perform the operation now. Try again later.
Articles 1–16